Market capitalization | $8.85b |
Enterprise Value | $11.16b |
P/E (TTM) P/E ratio | 28.12 |
EV/FCF (TTM) EV/FCF | 71.22 |
EV/Sales (TTM) EV/Sales | 3.44 |
P/S ratio (TTM) P/S ratio | 2.73 |
P/B ratio (TTM) P/B ratio | 4.90 |
Dividend yield | 0.34% |
Last dividend (FY24) | $0.20 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
15 Analysts have issued a Bruker Corporation forecast:
15 Analysts have issued a Bruker Corporation forecast:
Sep '24 |
+/-
%
|
||
Revenue | 3,241 3,241 |
15%
15%
|
|
Gross Profit | 1,598 1,598 |
10%
10%
|
|
EBITDA | 546 546 |
4%
4%
|
EBIT (Operating Income) EBIT | 378 378 |
20%
20%
|
Net Profit | 305 305 |
4%
4%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.
Head office | United States |
CEO | Frank Laukien |
Employees | 9,707 |
Founded | 1960 |
Website | www.bruker.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.